BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 17051568)

  • 1. Abnormal liver enzymes 2-3 months after liver transplantation in a patient with hepatitis C: Report of a case.
    Watt KD
    Liver Transpl; 2006 Nov; 12(11 Suppl 2):S29-31. PubMed ID: 17051568
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired initial function in liver grafts from donors > 50 years of age.
    Buckel E; Sanchez-Urdazpal L; Steers J; Sterioff S; Wiesner R; Krom RA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1558-9. PubMed ID: 8442188
    [No Abstract]   [Full Text] [Related]  

  • 4. Can serum liver function tests differentiate rejection from other causes of liver dysfunction after hepatic transplantation?
    Sankary HN; Williams JW; Foster PF
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):669-70. PubMed ID: 3055469
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver transplantation of shipped allografts.
    Rafecas A; Ribas Y; Figueras J; Aranda H; Ramos E; Fradera R; Fabregat J; Torras J; Jaurrieta E
    Transplant Proc; 1995 Aug; 27(4):2286-7. PubMed ID: 7652808
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient hyperphosphatasemia after liver transplantation in infancy.
    Lachaux A; Chambon M; Boillot O; Le Gall C; Loras I; Canterino I; Pouillaude JM; Gille D; David L; Hermier M
    Transplant Proc; 1996 Oct; 28(5):2847. PubMed ID: 8908095
    [No Abstract]   [Full Text] [Related]  

  • 7. Expanding organ availability by using hepatitis C antibody positive donors.
    Aswad S; Mendez R; Weingart RG; Mendez R
    Transplant Proc; 1993 Jun; 25(3):2270-1. PubMed ID: 7685947
    [No Abstract]   [Full Text] [Related]  

  • 8. Human hepatocyte growth factor serum levels in early stages after orthotopic liver transplantation.
    Hrusovsky S; Tsubouchi H; Remy-Martin A; Jouvenot M; Adessi GL; Rouget C; Mantion G; Heyd B; Chabod P; Bresson S
    Transplant Proc; 1994 Dec; 26(6):3618-9. PubMed ID: 7998295
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged observations on the liver function tests in infectious hepatitis.
    Strickland GT; Castell DO; Kronmal RA
    Am J Gastroenterol; 1971 Mar; 55(3):257-64. PubMed ID: 5578089
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined procurement of liver and pancreas does not influence early graft function and survival.
    Kim SC; Lee SG; Han DJ; Lee YJ; Kwon TW; Park KM; Choi BW; Min PC
    Transplant Proc; 1996 Jun; 28(3):1882-4. PubMed ID: 8658929
    [No Abstract]   [Full Text] [Related]  

  • 11. Donor characteristics for liver transplantation and risk factors for early poor graft function and survival.
    Lee YJ; Lee SG; Kwon TW; Park KM; Kim SC; Min PC
    Transplant Proc; 1996 Jun; 28(3):1663-4. PubMed ID: 8658828
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation.
    Gozzo ML; Avolio AW; Colacicco L; Agnes S; Forni F; Barbaresi G; Castagneto M
    Transplant Proc; 1993 Apr; 25(2):1760-1. PubMed ID: 8097065
    [No Abstract]   [Full Text] [Related]  

  • 13. De novo hepatitis B virus infection after orthotopic liver transplantation.
    Liu PP; Chen CL; Chen YS; Tai DI
    Transplant Proc; 1996 Jun; 28(3):1684-6. PubMed ID: 8658839
    [No Abstract]   [Full Text] [Related]  

  • 14. Ex vivo perfusion of livers with anti-class II antibody and acute rejection in canine liver transplantation.
    Sakagami K; Saito S; Kurozumi Y; Kobayashi N; Fujiwara T; Matsuno T; Orita K
    Transplant Proc; 1993 Apr; 25(2):1959-61. PubMed ID: 8470243
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinicochemical studies on 2 patients following homologous liver transplantation].
    Breuer J; Lie TS; Breuer H
    Z Klin Chem Klin Biochem; 1970 May; 8(3):249-53. PubMed ID: 4919198
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ergometric studies of body tolerance in patients with chronic liver disease].
    Franken FH; Wiechers B
    Dtsch Med Wochenschr; 1973 Mar; 98(11):528-31. PubMed ID: 4694994
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunobiology of hepatic nonparenchymal cells and ex vivo perfusion of the livers with anti-class II antibody: a strategy to prevent hepatic rejection in the dog.
    Sakagami K; Kurozumi Y; Tanakaya K; Saito S; Fujiwara T; Inagaki M; Matsuno T; Takasu S; Higaki K; Toda K
    Transplant Proc; 1995 Feb; 27(1):533-6. PubMed ID: 7879090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early diagnosis of chronic hepatitis].
    Novikov VS; Mironenko VA; Shusterov MI; Lezhenina NP
    Voen Med Zh; 1984 Apr; (4):36-8. PubMed ID: 6730371
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reversible liver function impairement in patients with hypernephroma].
    Linhart P; Heilmann K; Weizel A
    Dtsch Med Wochenschr; 1971 Jan; 96(1):29-35. PubMed ID: 5540001
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.